Nuclease protection assays (NPAs), including both ribonuclease protection assays (RPAs) and S1 nuclease assays, are an extremely sensitive method for the detection, quantitation and mapping of specific RNAs in a complex mixture of total cellular RNA. The basis of NPAs is a solution hybridization of a single-stranded, discrete sized antisense probe(s) to an RNA sample (see Figure 1). The small volume solution hybridization is far more efficient than more common membrane-based hybridization, and can accommodate up to 100 g of total or poly(A) RNA. After hybridization, any remaining unhybridized probe and sample RNA are removed by digestion with a mixture of nucleases. Then, in a single step reaction, the nucleases are inactivated and the remaining probe:target hybrids are precipitated. These products are separated on a denaturing polyacrylamide gel and are visualized by autoradiography. If nonisotopic probes are used, samples are visualized by transferring the gel to a membrane and performing secondary detection.
Figure 1. Detection of Specific mRNA Species Using a Nuclease Protection Assay.
NPAs are the method of choice for the simultaneous detection of several RNA s RPA Kit 100 rxns 7140 RNA Century Markers 50 g 7145 RNA Century-Plus Markers 50 g 7175 BrightStar Biotinylated RNA Century Markers 50 lanes 7180 BrightStar Biotinylated RNA Century-Plus Markers 50 lanes 7780 Century Marker Templates 5 g 7782 Century-Plus Marker Templates 5 g pecies. During solution hybridization and subsequent analysis, individual probe/target interactions are completely independent of one another. Thus, several RNA targets and internal controls can be assayed simultaneously (up to twelve have been used in the same reaction), provided that the protected fragment of individual probes are of different lengths. NPAs are also commonly used to precisely map mRNA termini and intron/exon junctions.
To quantitate mRNA levels using NPAs, the intensities of probe fragments protected by the sample RNA are compared to the intensities generated from either an endogenous internal control (relative quantitation) or known amounts of sense strand RNA (absolute quantitation). For more information on using NPAs for quantitation, see Technical Bulletin 151, "Use of Internal and External Standards or Reference RNAs for Accurate Quantitation of RNA Levels."
Figure 2. Simultaneous Quantitation of Multiple mRNAs Using the RPA III Kit. Ten micrograms of various mouse tissue total RNAs were hybridized overnight with approximately 50,000 cpm each of seven distinct probe transcripts. Nuclease digestion, product separation on a denaturing 6% acrylamide gel, and a four-hour exposure to film at -80C were used to assess hybridization levels. The radiolabeled probes were synthesized in 5 l transcription reactions using Ambion's MAXIscript Kit with [-32P]UTP (800 Ci/mmol, 10 Ci/ml) and gel purified prior to hybridization. The specific activities of the cyclophilin and -actin probes were reduced twenty and 200-fold, respectively, by adding appropriate amounts of non-radioactive UTP to the transcription reaction.
Advanta ges of NPAs over RT-PCR Reactions
The primary limitation of NPAs is the lack of information on transcript size. The portion of probe homologous to target RNA determines the size of the protected fragment. Another drawback to NPAs is the lack of probe flexibility. The most common type of NPA, the ribonuclease protection assay, requires the use of RNA probes. Oligonucleotides and other single-stranded DNA probes can only be used in assays containing S1 nuclease. A region of the single-stranded, antisense probe must typically be completely homologous to target RNA to prevent cleavage of the probe:target hybrid by nuclease. This means that partially related sequences (e.g., probe and target RNA from different species) usually cannot be used.
There are a number of protocols, techniques and commercially available kits that can be used to isolate RNA for NPAs, i.e., most if not all RNA isolation methods are compatible with NPAs. RNA isolation techniques all share these common attributes:
Ambion provides several options for isolation of total RNA and mRNA that are compatible with a variety of cells and tissues, including bacteria, yeast, plant and animal. For a further discussion of RNA isolation options, see RNA Isolation: The Basics.
It is essential that probes used in NPA analysis are all of a discrete length. High specific activity single-stranded RNA probes can be produced by in vitro transcription reactions using Ambion's MAXIscript Kit. To assure that the probe is full length we recommend gel purification. Ambion's Technical Bulletin 171 discusses gel purification of probes in detail.
Either radiolabeled or nonisotopically labeled probes can be used for NPA analysis. We recommend that nonisotopic nucleotides be incorporated enzymatically (versus post synthesis chemical labeling of probes). Technical Bulletin 173, "Methods for Nonisotopic Labeling," describes how the MAXIscript Kit can be used to incorporate nonisotopic nucleotides into RNA probes.
For accurate quantitation of a specific message, probe concentration must be in molar excess over the t arget mRNA. This necessitates the use of low specific activity probes for abundant targets. For moderately abundant messages (e.g., -actin, GAPDH, or cyclophilin), a 1:50 dilution of labeled NTP with "cold" NTP should be used to increase the molar amount of probe made while simultaneously reducing the specific activity of the probe. For very abundant messages (e.g., 18S rRNA or 28S rRNA), a 1:10,000 dilution with "cold" NTP should be used.
For more information to help you choose the kit which is ideal for your needs, read "Which Nuclease Protection Assay Kit Is Right for Me?"
Cat# Product Name Size 1308 MAXIscript SP6 Kit 30 rxns 1310 MAXIscript SP6 Kit 100 rxns 1312 MAXIscript T7 Kit 30 rxns 1314 MAXIscript T7 Kit 100 rxns 1316 MAXIscript T3 Kit 30 rxns 1318 MAXIscript T3 Kit 100 rxns 1320 MAXIscript SP6/T7 Kit 15 rxns each 1322 MAXIscript SP6/T7 Kit 50 rxns each 1324 MAXIscript T7/T3 Kit 15 rxns each 1326 MAXIscript T7/T3 Kit 50 rxns each 1410 RPA II 120 rxns 1412 HybSpeed RPA Kit 100 rxns 1414 RPA III Ribonuclease Protection Assay Kit 100 rxns 1415 RPA III Ribonuclease Protection Assay Kit 35 rxns 1420 Direct Protect Lysate